Bupropion XR Sandoz 150 mg, Retardtabletten - 10 Swissmedic Key 68628001 Registration Holder Sandoz Pharmaceuticals AG Name Bupropion XR Sandoz 150 mg, Retardtabletten Date of registration 12.12.2023 Introduction of Sequence 12.12.2023 ATC-Classification Bupropion (N06AX12) Revision date WHO WHO-DDD Valid until 11.12.2028 Index Therapeuticus (BSV) 01.06. Show package size 10 Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680686280014 Medication Code Synthetika Pharmacode Disponibility
Composition bupropioni hydrochloridum 150 mg, povidonum K 90, acidum hydrochloridum, natrii stearylis fumaras corresp. natrium 0.309 mg, ethylcellulosum, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis anhydrica, macrogolum 1500, triethylis citras, Überzug: hypromellosum, macrogolum 400, macrogolum 8000, pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Bupropion Hydrochloride 150 mg
BAG: Active Agent Dose Bupropion Hydrochloride 150 mg
Inactive agents Dose additional_information Acidi Methacrylici Acidum Hydrochloridum Ethylcellulosum Ethylis Acrylatis Polymerisatum Hydroxypropylcellulosum Hypromellosum Überzug Macrogol 8000 Natrii Stearylis Fumaras Povidonum K 90 Pro Compresso Obducto Silica Colloidalis Anhydrica Triethylis Citras
Source Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
